戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  and is a tumor suppressor in esophageal and nasopharyngeal cancer.
2 yngeal, 7 (35%) for laryngeal, or 1 (5%) for nasopharyngeal cancer.
3 r (TCR) sequences for the early detection of nasopharyngeal cancer.
4 y versus radiotherapy alone in patients with nasopharyngeal cancers.
5 ctal, lung, oesophageal, stomach, liver, and nasopharyngeal cancers.
6 15 men with upper airway cancer (including 1 nasopharyngeal cancer), 92 men with leukemia, and 45 men
7 isease as well as EBV-positive lymphomas and nasopharyngeal cancer, although a recent study also show
8  our method by validating its predictions in nasopharyngeal cancer and colorectal cancer using whole
9 o cancers with an epithelial origin, such as nasopharyngeal cancer and gastric cancer, as well as mul
10 nd migration of EBV-related cancers, such as nasopharyngeal cancer and gastric cancer.
11    Respiratory tract cancers, including both nasopharyngeal cancer and lung cancer, are strongly asso
12  sequence were similar to those described in nasopharyngeal cancer and lymphoma tissues, including tw
13 ved in the development and/or progression of nasopharyngeal cancer and suggest that RB2/p130 could be
14                                    Childhood nasopharyngeal cancers are often diagnosed at an advance
15 posure-response relation with mortality from nasopharyngeal cancer (based on small numbers) but not f
16 ns on activity against the growth of a human nasopharyngeal cancer cell line KB and its P-gp 170 over
17 rally infected epithelial gastric cancer and nasopharyngeal cancer cell lines.
18 oliferation, migration, invasion, and EMT in nasopharyngeal cancer cells.
19  well as survival for patients with advanced nasopharyngeal cancer compared with standard RT alone.
20 risk-targeted screening program for oral and nasopharyngeal cancers could improve diagnosis and patie
21 s could serve as a geographical indicator of nasopharyngeal cancer incidence and mortality, while the
22 technique for treatment of locally recurrent nasopharyngeal cancer (lrNPC).
23                           Relative risks for nasopharyngeal cancer (nine deaths) increased with avera
24 sidered the gold standard screening test for nasopharyngeal cancer (NPC) in high-risk populations.
25                                              Nasopharyngeal cancer (NPC) is an Epstein-Barr virus (EB
26                                              Nasopharyngeal cancer (NPC), endemic in Southeast Asia,
27 h a nonrandomized cohort of 51 patients with nasopharyngeal cancer treated with 70-Gy standard fracti
28 adiotherapy alone for patients with advanced nasopharyngeal cancers with respect to PFS and overall s